I read a couple of books recently that, while I’d not like to take a three-hour final on them, nudged my brain out of neutral ...

I'll examine recent news around the company, its drug pipeline, and what Wall Street is saying to get a better handle on this question. Edgewise currently has two drugs that are driving the company.